Azelastine Nasal Spray for Prevention of SARS-CoV-2 Infections
SEP 2, 202511 MIN
Azelastine Nasal Spray for Prevention of SARS-CoV-2 Infections
SEP 2, 202511 MIN
Description
Interview with Robert Bals, MD, PhD, author of Azelastine Nasal Spray for Prevention of SARS-CoV-2 Infections: A Phase 2 Randomized Clinical Trial, and Dan H. Barouch, MD, PhD, author of A Novel Approach for Preventing Respiratory Virus Infections. Hosted by Eve Rittenberg, MD. Related Content: Azelastine Nasal Spray for Prevention of SARS-CoV-2 Infections A Novel Approach for Preventing Respiratory Virus Infections